EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Recent Glycemia Is a Major Determinant of β-Cell Function in Type 2 Diabetes Mellitus

Ji Yoon Kim, Jiyoon Lee, Sin Gon Kim, Nam Hoon Kim

Diabetes & Metabolism Journal · 30.11.2024 · 48 (6) · 1135-1146

DOI: 10.4093/dmj.2023.0359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 30.11.2024. Verfasst von Ji Yoon Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin-Secreting Cells, Glycated Hemoglobin, Blood Glucose. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Diabetes Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Progressive deterioration of β-cell function is a characteristic of type 2 diabetes mellitus (T2DM). We aimed to investigate the relative contributions of clinical factors to β-cell function in T2DM.

Methods

In a T2DM cohort of 470 adults (disease duration 0 to 41 years), β-cell function was estimated using insulinogenic index (IGI), disposition index (DI), oral disposition index (DIO), and homeostasis model assessment of β-cell function (HOMA-B) derived from a 75 g oral glucose tolerance test (OGTT). The relative contributions of age, sex, disease duration, body mass index, glycosylated hemoglobin (HbA1c) levels (at the time of the OGTT), area under the curve of HbA1c over time (HbA1c AUC), coefficient of variation in HbA1c (HbA1c CV), and antidiabetic agents use were compared by standardized regression coefficients. Longitudinal analyses of these indices were also performed.

Results

IGI, DI, DIO, and HOMA-B declined over time (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Insulin-Secreting CellsGlycated HemoglobinBlood GlucoseGlucose Tolerance TestHumansMaleFemaleMiddle AgedAdultAgedInsulin ResistanceHypoglycemic AgentsInsulinBody Mass Index

Stichwörter der Autor:innen

Diabetes mellitus, type 2Glycemic controlInsulin secretion

Substanzen

Glycated HemoglobinBlood GlucoseHypoglycemic Agentshemoglobin A1c protein, humanInsulin

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Förderung

  • Korean Diabetes Association

Zitieren

APA

Kim, J. Y., Lee, J., Kim, S. G., & Kim, N. H. (2024). Recent Glycemia Is a Major Determinant of β-Cell Function in Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal, 48(6), 1135-1146. https://doi.org/10.4093/dmj.2023.0359

Vancouver

Kim JY, Lee J, Kim SG, Kim NH. Recent Glycemia Is a Major Determinant of β-Cell Function in Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal. 2024;48(6):1135-1146. doi:10.4093/dmj.2023.0359

BibTeX
@article{Kim2024,
  author = {Kim, Ji Yoon and Lee, Jiyoon and Kim, Sin Gon and Kim, Nam Hoon},
  title = {Recent Glycemia Is a Major Determinant of β-Cell Function in Type 2 Diabetes Mellitus},
  journal = {Diabetes & Metabolism Journal},
  year = {2024},
  volume = {48},
  number = {6},
  pages = {1135--1146},
  doi = {10.4093/dmj.2023.0359}
}
Kostenlos starten →